The addition of chloroquine and bevacizumab to standard radiochemotherapy for recurrent glioblastoma multiforme.

Witte, Hanno M; Riecke, Armin; Steinestel, Konrad; Schulz, Chris; Küchler, Jan; Gebauer, Niklas; Tronnier, Volker; Leppert, Jan

Witte, Hanno M; Riecke, Armin; Steinestel, Konrad; Schulz, Chris; Küchler, Jan; Gebauer, Niklas; Tronnier, Volker; Leppert, Jan.

Afiliação

Witte HM; Department of Haematology and Oncology, German Armed Forces Hospital of Ulm, Ulm, Germany.
Riecke A; Department of Pathology and Molecular-Pathology, German Armed Forces Hospital of Ulm, Ulm, Germany.
Steinestel K; Department of Haematology and Oncology, University Hospital of Schleswig-Holstein, Luebeck, Germany.
Schulz C; Department of Haematology and Oncology, German Armed Forces Hospital of Ulm, Ulm, Germany.
Küchler J; Department of Pathology and Molecular-Pathology, German Armed Forces Hospital of Ulm, Ulm, Germany.
Gebauer N; Department of Neurosurgery, German Armed Forces Hospital of Ulm, Ulm, Germany.
Tronnier V; Department of Neurosurgery, University Hospital of Schleswig-Holstein, Luebeck, Germany.
Leppert J; Department of Haematology and Oncology, University Hospital of Schleswig-Holstein, Luebeck, Germany.

Br J Neurosurg ; : 1-13, 2021 Feb 16.

Article em En | MEDLINE | ID: mdl-33590799

Palavras-chave

Glioblastoma multiforme; autophagy; bevacizumab; chloroquine; radiochemotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Br J Neurosurg Assunto da revista: NEUROCIRURGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google